2014~2016年我院抗过敏组胺药的临床应用统计

Abstract
Figure/Table
References (30)
Related Citation (2)

Download: PDF (484 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical utilization situation of antihistamine drugs in Hanzhong Central Hospital ("our hospital" for short), so as to provide references for clinical rational drug use. Methods The total drug sales amounts and sort, DDDs, DDC and sort ratio (B/A) of antihistamine drugs in our hospital from 2014 to 2016 were retrospectively analyzed. Results In the past three years, the trend of total drug sales amount of antihistamine agents decreased year by year, especially the first generation of antiallergic histamines. The sales amount sorting of all kinds of antihistamine drugs had few changes, Desloratadine Citrate Disodium Tablet and Desloratadine Tablet ranked the top two, rankings of Cetirizine raised year after year, other drugs sorting changed slightly. The top three DDDs of antihistamine drugs were the third generation of antiallergic histamines, drugs with Chloropressin composition always ranked the front of the list. The B/A values of Cetirizine Drops were always <1, and the B/A values of Chlorobenzene and Isopropyrazine were all >1. There were irrational use of antihistamine drugs in prescriptions, including improper drug combination, improper dosage, improper frequency for drugs giving, with total of 213 cases. Conclusion The DDDs sort of antihistamine drugs in our hospital is basically reasonable, but the clinical rational application of the second and third generation of antihistamine drugs should be further strengthened, in order to reduce improper use of drugs.

Key words： Antihistamine drugs Consumption sum DDDs Medication analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Wei

Cite this article:

LI Wei. Clinical application statistics of antihistamine drugs in our hospital from 2014 to 2016[J]. 中国医药导报, 2017, 14(26): 126-129.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2017/V14/I26/126

[1] Feng B，Jin H，Xiang H，et al. Association of pediatric allergic rhinitis with the ratings of attention-deficit/hyperactivity disorder [J]. Am J Rhinol Allergy，2017，31（3）：161-167.
[2] Recto MST，Genuino MLG，Castor MAR，et al. Dietary primary prevention of allergic diseases in children：the Philippine guidelines [J]. Asia Pac Allergy，2017，7（2）：102-114.
[3] 尹佳.中国变态反应事业迎来新的发展契机中华医学会变态反应学分会2013年全国学术会议开幕致辞[J].中华临床免疫和变态反应杂志，2014，8（1）：1-2.
[4] Yun Y，Son J，Kim K，et al. Effectiveness and safety of combination treatment of herbal medicines and oral antihistamines for atopic dermatitis： a retrospective chart review [J]. Integr Med Res，2017，6（1）：19-25.
[5] Yanai K，Yoshikawa T，Yanai A，et al. The clinical pharmacology of non-sedating antihistamines [J]. Pharmacol Ther，2017，27（17）：30107-30109.
[6] 陈新谦，金有豫，汤光.新编药物学[M].17版.北京：人民卫生出版社，2011.
[7] Yun Y，Son J，Kim K，et al. Effectiveness and safety of combination treatment of herbal medicines and oral antihistamines for atopic dermatitis： a retrospective chart review [J]. Integr Med Res，2017，6（1）：19-25.
[8] Vestergaard C，Toubi E，Maurer M，et al. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines：an expert opinion [J]. Eur J Dermatol，2017， 27（1）：10-19.
[9] Terevnikov V，Stenberg JH，Tiihonen J，et al. Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics [J]. Nord J Psychiatry，2017，71（1）：77-80.
[10] Kizu J. Patients Taking Antihistamines and Their Effects on Driving [J]. Yakugaku Zasshi，2017，137（3）：315-321.
[11] Kanamitsu K，Nozaki Y，Nagaya Y，et al. Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data [J]. Drug Metab Pharmacokinet，2017，32（2）：135-144.
[12] 闵红霞.2011-2014年我所第二、三代抗组胺药应用调查[J].临床合理用药杂志，2015，8（26）：74-76.
[13] Vestergaard C，Toubi E，Maurer M，et al. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines： an expert opinion [J]. Eur J Dermatol，2017，27（1）：10-19.
[14] Saguil A，Mercado M. Second-Generation H1-Antihistamines for Chronic Spontaneous Urticaria [J]. Am Fam Physician，2016，94（5）：352-353.
[15] 陆忆，殷敏，程雷，等.白三烯受体拮抗剂孟鲁司特治疗变应性鼻炎的荟萃分析[J].中华耳鼻咽喉头颈外科杂志，2014，49（8）：659-667.
[16] Khazaie H，Ghadami MR，Knight DC，et al. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms： a randomized clinical trial [J]. Psychiatry Res，2013，210（3）：901-905.
[17] Weinstein ME，Wolff AH，Bielory L. Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria：a meta-analysis [J]. Ann Allergy Asthma Immunol，2010，104（6）：518-522.
[18] More SS，Li S，Yee SW，et al. Organic cation transporters modulate the uptake and cytotoxicity of picoplatin，a third-generation platinum analogue [J]. Mol Cancer Ther，2010， 9（4）：1058-1069.
[19] Hay JW，Kaliner MA. Costs of second-generation antihistamines in the treatment of allergic rhinitis：US perspective [J]. Curr Med Res Opin，2009，25（6）：1421-1431.
[20] Vestergaard C，Toubi E，Maurer M，et al. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines： an expert opinion [J]. Eur J Dermatol，2017，27（1）：10-19.
[21] 闫燕，李鹏，刘丹丹，等.孟鲁司特钠、布地奈德鼻喷剂、枸地氯雷他定联合治疗变应性鼻炎的疗效及对炎性因子的影响[J].中国药师，2016，19（10）：1900-1901.
[22] 董东，何小亮，杨德勇，等.枸地氯雷他定与阿伐斯汀递减疗法治疗慢性荨麻疹的疗效比较[J].中国药房，2015， 26（36）：5078-5080.
[23] 周顺龙，许恩超，邓雯，等.氯雷他定联合地氯雷他定治疗儿童慢性自发性荨麻疹的临床观察[J].中华皮肤科杂志，2017，50（1）：46-48.
[24] Antonijoan R，Coimbra J，García-Gea C，et al. Comparative efficacy of bilastine，desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers [J]. Curr Med Res Opin，2017，33（1）：129-136.
[25] Li J，Guo A，Chen W，et al. Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine [J]. J Allergy Clin Immunol，2017，139（4）：1386-1388.
[26] Liccardi G，Calzetta L，Salzillo A，et al. Is H1-antihistamine（desloratadine 5 mg，orodispersible tablet）premedication in NSAID-associated urticaria really safe and practicable in "real life"?[J]. J Allergy Clin Immunol Pract，2017，5（2）：535.
[27] 余佳林，刘军，黄闰娣，等.舌下含服标准化尘螨变应原疫苗滴剂治疗荨麻疹的临床观察[J].中国医药科学，2017， 7（7）：168-170.DOI：10.3969/j.issn.2095-0616.2017.07.050.
[28] 侯其刚，汤利芹.枸地氯雷他定不同剂量方案治疗慢性荨麻疹的效果对比[J].中国当代医药，2017，24（3）：61-63，67.
[29] 巫艳芬，王玉梅，王永华，等.盐酸异丙嗪片与盐酸西替利嗪片联合治疗慢性荨麻疹的疗效观察[J].中国医药科学，2017，7（1）：81-83.DOI：10.3969/j.issn.2095-0616. 2017.01.023.
[30] 中华医学会皮肤性病学分会，中华医学会皮肤性病学分会免疫学组.中国荨麻疹诊疗指南（2014版）[J].中华皮肤科杂志，2014，47（7）：514-516.